The Effects of Sacran, a Sulfated Polysaccharide, on Gut Microbiota Using Chronic Kidney Disease Model Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Effects of Sacran, a Sulfated Polysaccharide, on Gut Microbiota Using Chronic Kidney Disease Model Rats

Published:2022-05-01 Issue:5 Volume:45 Page:576-582
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Goto Miwa¹,Kobira Yusei¹,Kaneko Shinichiro²,Arima Hidetoshi³,Michihara Akihiro⁴,Azuma Kazuo⁵,Higashi Taishi⁶,Motoyama Keiichi⁶,Watanabe Hiroshi⁶,Maruyama Toru⁶,Kadowaki Daisuke¹,Otagiri Masaki¹,Iohara Daisuke⁷,Hirayama Fumitoshi¹,Anraku Makoto¹

Affiliation:

1. Faculty of Pharmaceutical Sciences, Sojo University

2. Green Science Material, Inc.

3. Daiichi University of Pharmacy

4. Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University

5. Department of Veterinary Clinical Medicine, Tottori University

6. Graduate School of Pharmaceutical Sciences, Kumamoto University

7. DDS Research Institute, Sojo University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/5/45_b21-00897/_pdf

Reference36 articles.

1. 1) Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins (Basel), 13, 142 (2021).

2. 2) Niwa T. The role of carbon adsorbent in the conservative management of chronic kidney disease. Panminerva Med., 59, 139–148 (2017).

3. 3) Niwa T. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120. Ther. Apher. Dial., 15, 120–124 (2011).

4. 4) Opdebeeck B, Maudsley S, Azmi A, De Maré A, De Leger W, Meijers B, Verhulst A, Evenepoel P, D’Haese PC, Neven E. Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance. J. Am. Soc. Nephrol., 30, 751–766 (2019).

5. 5) Takkavatakarn K, Wuttiputinun T, Phannajit J, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. J. Nephrol., 34, 1805–1817 (2021).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury;Pharmacological Research;2024-09

2. Therapeutic mechanism exploration of polysaccharides from Dendrobium officinale on unilateral ureteral obstruction operation-induced renal fibrosis based on improving oxidative stress injury mediated by AhR/NOX4 pathway;International Journal of Biological Macromolecules;2023-12

3. Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation;Frontiers in Pharmacology;2023-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3